Corcept Therapeutics Inc (CORT)
25.36
+0.61
(+2.46%)
USD |
NASDAQ |
Mar 27, 16:00
25.34
-0.02
(-0.08%)
After-Hours: 20:00
Corcept Therapeutics Free Cash Flow (Quarterly): 5.887M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.887M |
September 30, 2023 | 52.87M |
June 30, 2023 | 42.18M |
March 31, 2023 | 25.96M |
December 31, 2022 | 33.36M |
September 30, 2022 | 33.30M |
June 30, 2022 | 18.02M |
March 31, 2022 | 35.24M |
December 31, 2021 | 49.36M |
September 30, 2021 | 48.54M |
June 30, 2021 | 44.22M |
March 31, 2021 | 25.30M |
December 31, 2020 | 34.64M |
September 30, 2020 | 29.73M |
June 30, 2020 | 53.14M |
March 31, 2020 | 33.23M |
December 31, 2019 | 48.32M |
September 30, 2019 | 38.14M |
June 30, 2019 | 25.14M |
March 31, 2019 | 23.42M |
December 31, 2018 | 21.41M |
September 30, 2018 | 44.46M |
June 30, 2018 | 15.15M |
March 31, 2018 | 34.35M |
December 31, 2017 | 24.85M |
Date | Value |
---|---|
September 30, 2017 | 10.84M |
June 30, 2017 | 15.37M |
March 31, 2017 | 9.451M |
December 31, 2016 | 4.494M |
September 30, 2016 | 8.845M |
June 30, 2016 | 1.583M |
March 31, 2016 | 3.275M |
December 31, 2015 | 4.18M |
September 30, 2015 | 0.883M |
June 30, 2015 | -0.139M |
March 31, 2015 | -1.811M |
December 31, 2014 | -1.403M |
September 30, 2014 | -5.945M |
June 30, 2014 | -9.032M |
March 31, 2014 | -11.17M |
December 31, 2013 | -7.706M |
September 30, 2013 | -8.667M |
June 30, 2013 | -9.24M |
March 31, 2013 | -11.57M |
December 31, 2012 | -8.80M |
September 30, 2012 | -9.281M |
June 30, 2012 | -7.926M |
March 31, 2012 | -10.16M |
December 31, 2011 | -6.294M |
September 30, 2011 | -6.604M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
5.887M
Minimum
Dec 2023
53.14M
Maximum
Jun 2020
35.00M
Average
34.00M
Median
Free Cash Flow (Quarterly) Benchmarks
Puma Biotechnology Inc | 10.41M |
Anavex Life Sciences Corp | -7.318M |
Ultragenyx Pharmaceutical Inc | -85.50M |
Voyager Therapeutics Inc | -24.52M |
Aditxt Inc | -8.043M |